| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVID | Common Stock | Purchase | $6.18M | +250K | +3.63% | $24.73 | 7.13M | May 16, 2022 | See Footnote | F1, F2 |
| transaction | AVID | Common Stock | Award | $0 | +6.24K | +20.58% | $0.00 | 36.6K | May 18, 2022 | Direct | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | This Form 4 is filed jointly by Impactive Capital GP LLC ("Impactive GP"), Impactive Capital LP ("Impactive Capital"), Impactive Capital LLC ("Impactive Capital GP"), Lauren Taylor Wolfe and Christian Asmar (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his, her or its pecuniary interest therein. |
| F2 | Securities of the Issuer beneficially owned by Impactive GP and Impactive Capital. As the general partner of Impactive Capital, Impactive Capital GP may be deemed to beneficially own the securities of the Issuer beneficially owned by Impactive Capital. As managing members of each of Impactive GP and Impactive Capital GP, each of Ms. Taylor Wolfe and Mr. Asmar may be deemed to beneficially own the securities of the Issuer beneficially owned by Impactive GP and Impactive Capital GP. |
| F3 | Represents an award of restricted stock units ("RSUs") that will vest in full on the earlier of the date of the Company's 2023 Annual Meeting or May 18, 2023. Each RSU represents the contingent right to receive one share of the Issuer's common stock. |
| F4 | Securities of the Issuer directly beneficially owned by Mr. Asmar, including 6,242 shares of Common Stock underlying certain RSUs, which will vest in full on the earlier of the date of the Issuer's 2023 Annual Meeting of Stockholders or May 18, 2023. |